AU2001285944A1 - Fungicidal agent containing n-chlorotaurine and use thereof - Google Patents

Fungicidal agent containing n-chlorotaurine and use thereof

Info

Publication number
AU2001285944A1
AU2001285944A1 AU2001285944A AU8594401A AU2001285944A1 AU 2001285944 A1 AU2001285944 A1 AU 2001285944A1 AU 2001285944 A AU2001285944 A AU 2001285944A AU 8594401 A AU8594401 A AU 8594401A AU 2001285944 A1 AU2001285944 A1 AU 2001285944A1
Authority
AU
Australia
Prior art keywords
chlorotaurine
fungicidal agent
agent containing
fungicidal
salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001285944A
Inventor
Waldemar Gottardi
Markus Nagl
Andreas Neher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2001285944A1 publication Critical patent/AU2001285944A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
  • Medicinal Preparation (AREA)

Abstract

A fungicidal agent for treating infectious diseases caused by fungi contains N-chlorotaurine or one of its salts in aqueous solution, optionally with customary pharmaceutical additives.
AU2001285944A 2000-09-14 2001-09-10 Fungicidal agent containing n-chlorotaurine and use thereof Abandoned AU2001285944A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10045868 2000-09-14
DE10045868 2000-09-14
PCT/EP2001/010437 WO2002022118A1 (en) 2000-09-14 2001-09-10 Fungicidal agent containing n-chlorotaurine and use thereof

Publications (1)

Publication Number Publication Date
AU2001285944A1 true AU2001285944A1 (en) 2002-03-26

Family

ID=7656459

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001285944A Abandoned AU2001285944A1 (en) 2000-09-14 2001-09-10 Fungicidal agent containing n-chlorotaurine and use thereof

Country Status (7)

Country Link
US (2) US20040116521A1 (en)
EP (1) EP1239853B1 (en)
AT (1) ATE344662T1 (en)
AU (1) AU2001285944A1 (en)
DE (1) DE50111407D1 (en)
ES (1) ES2276818T3 (en)
WO (1) WO2002022118A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003297807A1 (en) * 2002-12-06 2004-06-30 Pathogenics Llc Use of n-chlorotaurine for treatment of oozing tissue deficiencies
MXPA06001898A (en) 2003-08-18 2006-05-31 Novacal Pharmaceuticals Inc N,n-dihalogenated amino acids and derivatives.
AT501376B1 (en) * 2005-01-17 2010-11-15 Pregenzer Bruno GLUCCOOCORTICOID MEDICINAL PRODUCT
TWI386201B (en) 2005-01-25 2013-02-21 Novabay Pharmaceuticals Inc N-halogenated amino acids, n, n-dihalogenated amino acids and deriavtives; compositions and methods of using them
WO2007147085A2 (en) * 2006-06-14 2007-12-21 Novabay Pharmaceuticals, Inc. Treatment of wound using aganocides and negative pressure
US20080288019A1 (en) * 2007-01-31 2008-11-20 Adam Heller Electrochemical management of pain
WO2009126912A1 (en) 2008-04-10 2009-10-15 Novabay Pharmaceuticals, Inc. Compositions comprising n-halogenated or n, n-dihalogenated amine for treatment and prophylaxis of bronchopulmonary infections
PT3469117T (en) 2016-06-09 2022-03-08 De Nora Holdings Us Inc Electrolytic production of organic chloramine solutions
IT202100022790A1 (en) * 2021-09-02 2023-03-02 Synapticom S R L DISINFECTANT THERMOGEL CONTAINING SODIUM HYPOCHLORITE STABILIZED WITH PHYSIOLOGICAL PH TAURINE

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4356179A (en) * 1978-11-22 1982-10-26 Alfredo Petteruti Formaldehyde products as agricultural fungicides
US4556560A (en) * 1983-01-24 1985-12-03 The Procter & Gamble Company Methods for the treatment and prophylaxis of diaper rash and diaper dermatitis
AU641529B2 (en) * 1990-07-30 1993-09-23 Bloomfield D.A. Zwitterionic compounds and their N-halo derivatives for use in the treatment of clinical conditions
DE4041703C2 (en) * 1990-12-24 1993-10-21 Waldemar Dr Gottardi Alkali metal salts of N-chloro taurine in crystalline form, process for their preparation and their use
JP3759757B2 (en) * 1994-01-13 2006-03-29 相互薬工株式会社 Fungicide
US6033701A (en) * 1994-12-06 2000-03-07 Hirsch; Gerald Phillip Hydraulic pressure sterilization and preservation of foodstuff and feedstuff
DE19712565A1 (en) * 1997-03-25 1998-10-01 Thomas W Dr Stief Composition containing singlet oxygen or photon generator
PT1024814E (en) * 1997-10-22 2007-11-29 Mayo Foundation Use of antifungal agents for the topical treatment of fungus-induced mucositis

Also Published As

Publication number Publication date
EP1239853A1 (en) 2002-09-18
US20040116521A1 (en) 2004-06-17
ATE344662T1 (en) 2006-11-15
WO2002022118A1 (en) 2002-03-21
EP1239853B1 (en) 2006-11-08
ES2276818T3 (en) 2007-07-01
US20090182055A1 (en) 2009-07-16
DE50111407D1 (en) 2006-12-21

Similar Documents

Publication Publication Date Title
YU6303A (en) New heterocyclic compounds, their preparations and their use as medicaments, in particular as anti-bacterial agents
CU23367A3 (en) FORMULATION OF MOXIFLOXACINO WITH COMMON SALT
WO2004021968A3 (en) Solution for ungual application
SE0100901D0 (en) New composition
CO5580776A2 (en) STABLE PHARMACEUTICAL FORMULATION IN SOLUTION OF OXALIPLATIN
WO2002011764A3 (en) Pharmaceutical compositions
EE05419B1 (en) Substituted oxazolidinones for combination therapy
ATE323488T1 (en) NITRATE SALTS OF ANTIMICROBIAL ACTIVE INGREDIENTS
HK1053603A1 (en) Medicament based on gestagens for dermal application comprising ascorbic acid and/or salts thereof
MXPA03005505A (en) Modafinil compound and cyclodextrin mixtures.
MY130441A (en) Solutions containing epinastin
CO5180582A1 (en) PHARMACEUTICAL SOLUTIONS OF LEVOSIMENDAN
PL346764A1 (en) New oral formulation for 5-ht4
AU2001285944A1 (en) Fungicidal agent containing n-chlorotaurine and use thereof
GB2383041A (en) Process for the preparation of gabapentin
DE60137069D1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING MODAFINE COMPOUNDS
SE0102057D0 (en) New Salts I
AU2002223796A1 (en) Pleuromutilin derivatives with antimicrobial activity
AU2002365288A1 (en) Tropane derivatives having dopamine reuptake inhibitor activity for the treatment of ischemic diseases
AU2001258754A1 (en) Aqueous liquid preparation
EP1591130A3 (en) Use of active solution for disinfecting and/or sterilizing a dental unit and method thereof
SE0102058D0 (en) New Salts II
PE20020525A1 (en) COMPOSITIONS INCLUDING TIOTROPE SALTS AND ANTIHISTAMINE AGENTS
GR1004434B (en) Use of diflofenac or topically acceptable salt thereof for the treatment of burns
DE50202121D1 (en) METAL SALTS AS ANTIMYCOTICS